Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
18.31
-0.10 (-0.54%)
Jun 18, 2026, 4:00 PM EDT - Market closed
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $1.55 billion as of June 18, 2026. Its market cap has increased by 445.50% in one year.
Market Cap
1.55B
Enterprise Value
919.66M
1-Year Change
445.50%
Ranking
Category
Stock Price
$18.31
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has increased from $845.31M to $1.55B, an increase of 82.99%. That is a compound annual growth rate of 12.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 1.55B | 51.49% |
| Dec 31, 2025 | 1.02B | 139.48% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
| Jun 24, 2021 | 845.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Septerna | 1.63B |
| Palvella Therapeutics | 1.62B |
| Vir Biotechnology | 1.54B |
| Ascentage Pharma Group International | 1.54B |
| Bicara Therapeutics | 1.53B |
| GH Research | 1.53B |
| Novavax | 1.50B |
| SELLAS Life Sciences Group | 1.50B |